The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

FTSE 100 rises as healthcare, resource-linked gains offset China jitters

Mon, 16th May 2022 15:54

May 16 (Reuters) - UK's blue-chip index rose on Monday, aided by gains in healthcare and resource-linked stocks, though subdued data from China stoked slowdown concerns in the world's second-largest economy and kept sentiment in check.

The FTSE 100 index ended 0.6% higher, with pharmaceutical giants such as AstraZeneca and GlaxoSmithKline and oil majors Shell and BP among top boosts.

Data showed that China's retail and factory activity fell sharply in April as wide COVID-19 lockdowns confined workers and consumers to their homes and severely disrupted supply chains.

"It's no secret that there is some growth downside in China because of the zero-COVID strategy, so continue to expect the negative impact on data," Karim Chedid, head of investment strategy for iShares EMEA at BlackRock, said.

"The question is whether we've already seen the worst impact of the data."

Big miners including Glencore and Antofagasta rose along with industrial metal prices as China, the world's top metals consumer, set out plans to ease COVID-19 restrictions.

Consumer companies Unilever and Reckitt Benckiser were the biggest drags on the FTSE 100.

The domestically focussed midcap index ended flat.

Vodafone jumped 1.9% after telecoms group e& bought a 9.8% stake in the company for $4.4 billion.

Ryanair fell 0.2% after the airlines group said it was impossible to give a detailed forecast beyond hoping to return to "reasonable profitability" this year amid uncertainties over COVID-19 and the Ukraine war.

Technical products and services provider Diploma slid 5.7% after first-half results.

British baker and fast food chain Greggs slipped 0.5% after it said cost pressures were increasing as it reported a rise in first-quarter sales.

Bank of England Governor Andrew Bailey said he was "not at all happy" about the surge in inflation in Britain but added that he did not think the central bank could have done anything differently to prevent it. (Reporting by Sruthi Shankar and Amal S in Bengaluru; Editing by Aditya Soni, Rashmi Aich and Andrew Heavens)

Related Shares

More News
Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemi...

Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was ...

7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.